Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
LASIK anxiety runs deep, partly because the procedure involves a laser reshaping the cornea while the patient is awake and conscious. Prospective patients often picture permanent, sight-threatening loss as the typical outcome, when the FDA's PROWL studies found fewer than 1 in 100 participants experienced debilitating difficulty with usual activities from any one visual symptom. Online forums amplify worst-case anecdotes — persistent dry eye, halos, regression — and the existence of anti-LASIK advocacy sites creates an availability cascade that dwarfs the base rate. The same PROWL studies found that up to 28% of patients with no pre-operative dry eye reported symptoms at three months, and up to 40% reported new halos at three months, but these transient side effects are routinely conflated with permanent vision-threatening complications, which are rarer still.
Rough estimate: Many prospective patients expect permanent sight-threatening loss to be the typical outcome
Source: editorial intuition, not polled
Actual
<1 in 100 per procedure (debilitating symptoms)
US LASIK patients, all myopia corrections
Show derivation
The only figure the cited sources actually state for serious outcomes is the FDA PROWL finding that "less than 1 percent of study participants experienced 'a lot of difficulty' with or inability to do usual activities" because of any one visual symptom after LASIK — i.e. debilitating outcomes occur in fewer than 1 in 100 patients. The point estimate is set at this stated ceiling (0.01); the true rate is below it, and the lower bound of 0.001 reflects that per-symptom debilitating rates are lower still. Most adults who undergo LASIK do so once in a lifetime, so the activity-specific scope reflects the risk per person who elects the procedure, not the general population. Approximately 10 million Americans have had LASIK since FDA approval in 1999 out of ~260 million adults, so the unconditional population probability is far lower, but the relevant question is the risk conditional on choosing the surgery.
Caveats: The "less than 1 in 100" headline is the FDA PROWL figure for debilitating outco…
The "less than 1 in 100" headline is the FDA PROWL figure for debilitating outcomes — patients who experienced "a lot of difficulty" with or inability to do usual activities because of any one visual symptom after LASIK. It is an upper bound: the true rate is below 1%, and PROWL's sample (574 participants across the two studies) is too small to precisely estimate rarer sight-threatening events such as post-LASIK ectasia or significant permanent loss of best-corrected visual acuity, which the cited sources do not quantify. Transient dry eye (up to 28% at 3 months) and halos (up to 40% at 3 months) are common but mostly self-resolving within 6-12 months and are not counted in the debilitating-outcome figure. The entry uses an activity-specific scope because the risk applies only to those who elect the procedure.
Related risks
Other risks on similar themes — for exploring related fears.
Medication reaction
What are the odds of a serious adverse drug reaction from prescribed medication?
Opioid addiction
What are the odds of developing opioid addiction after a standard surgical prescription?
Benzo dependence
What are the odds of developing benzodiazepine dependence after a standard prescription?
Cat litter toxoplasmosis
What are the odds of acquiring a toxoplasma infection from cleaning a cat's litter box?
Childhood cancer diagnosis
What are the odds of a child being diagnosed with cancer before age 20?
Pick challenger
LASIK has been performed on more than 10 million Americans since FDA approval in 1999, and the data at scale tell a consistent story: debilitating outcomes are rare. The FDA’s PROWL studies — the agency’s prospective patient-reported-outcome assessment — found that in each study fewer than 1 percent of participants experienced “a lot of difficulty” with or inability to do usual activities because of any one visual symptom after LASIK, and that more than 95% of participants were satisfied with their vision. Rarer sight-threatening events such as post-LASIK ectasia or permanent loss of best-corrected vision sit below that 1-in-100 ceiling, but the PROWL sample of 574 participants is too small to pin their rate down precisely. Prospective patients tend to picture permanent vision loss as the typical result, when the documented debilitating-outcome rate is under 1 in 100 — which makes LASIK one of the more dramatically overrated surgical fears.
The confusion arises from conflating transient side effects with serious complications. Up to 28% of PROWL participants reported new dry eye symptoms at three months, and up to 40% reported new halos — numbers that sound alarming until you note that most of these symptoms resolve within six to twelve months as the corneal nerves regenerate. Persistent dry eye beyond one year affects a much smaller fraction, and the subset who develop genuinely debilitating chronic symptoms is smaller still. The anti-LASIK advocacy community, while representing real suffering, samples from the tail of the distribution and presents it as the central tendency.
The risk is not uniform. High myopia (above -8 diopters) and thin corneas (below 500 microns) are the primary risk factors for post-LASIK ectasia, the most feared structural complication. Modern screening protocols using corneal topography and tomography have substantially reduced ectasia incidence by identifying at-risk patients before surgery. The procedure’s safety profile has improved with each technology generation — wavefront-guided and femtosecond flap-creation platforms produce measurably better outcomes than the mechanical microkeratome era that generated many of the early complication statistics still cited online.
Related tidbits
Serious, sight-threatening LASIK complications run under 1 in 1,000 per procedure. Pre-op surveys find patients guessing 1 in 100 to 1 in 500 — overestimating by one to two orders of magnitude. Transient dry eye and halos are common; permanent vision loss is not.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
1/3 sources independently verified verbatim against the cited source
-
[1] US Food and Drug Administration — LASIK Quality of Life Collaboration Project (PROWL)
LASIK Quality of Life Collaboration Project (PROWL)- Statistic
Less than 1% experienced debilitating difficulty with usual activities; more than 95% satisfied with vision; up to 28% reported new dry eye symptoms and 40% new halos at 3 months post-op- Excerpt
“"In each of the PROWL studies, less than 1 percent of patients experienced difficulty performing usual activities following LASIK surgery due to any one symptom. ... Up to 28 percent of participants with no symptoms of dry eyes before LASIK, reported dry eye symptoms at three months after their surgery. Up to 40 percent of participants with no halos before LASIK had halos three months following surgery. ... More than 95% of participants were satisfied with their vision following LASIK surgery." ”
- Source data from
- 2021-06-17
- Accessed
- 2026-04-18 · archived copy
- Calculation
- The FDA PROWL studies (PROWL-1: 262 active-duty military, PROWL-2: 312 civilians) are prospective studies designed to measure patient-reported outcomes. The strongest serious-outcome figure the FDA states is that "less than 1 percent of study participants experienced 'a lot of difficulty' with or inability to do usual activities" because of any one visual symptom — this is the basis for the <1 in 100 native rate. Satisfaction is stated as "more than 95%" (the specific 96-98% band is not on this FDA page; it appears in the underlying JAMA PROWL publications). Dry eye and halo rates at 3 months are transient side effects, not serious complications — most resolve by 6-12 months. PROWL's sample size is too small to precisely estimate rarer sight-threatening events such as ectasia, so no tighter rate is asserted.
-
[2] Middle East African Journal of Ophthalmology (PMC) — Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic Astigmatism
Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic AstigmatismSee all 2 Likelier entries citing this source →
- Statistic
98.5% of patients satisfied or very satisfied with their surgery; uncorrected visual acuity 20/40 or better in 99% of eyes- Excerpt
“"A total of 98.5% of patients was satisfied or very satisfied with their surgery. Postoperatively, the uncorrected visual acuity was 20/40 or better in 99% of eyes and 96% of eyes were within ± 1.00 D of the targeted correction." ”
- Source data from
- 2014-10-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- This peer-reviewed study documents high patient satisfaction (98.5% satisfied or very satisfied) and excellent functional outcomes (20/40 or better uncorrected acuity in 99% of eyes). It reports satisfaction and refractive outcomes, not a quantified serious-complication rate; the native rate here is anchored to the FDA PROWL "less than 1 percent" debilitating-outcome figure, with this study supplying the satisfaction and efficacy context.
-
[3] Clinical Ophthalmology (PMC) — The 25th Anniversary of Laser Vision Correction in the United States Verified
The 25th Anniversary of Laser Vision Correction in the United States- Statistic
Over 10 million patients treated with laser vision correction in the US over 25 years; complication rates have declined with each technology generation- Excerpt
“"An estimated 20 to 25 million laser vision correction procedures represent 10 to 15 million patients treated in the past 25 years. Advances in diagnostic technology, surgical techniques, and excimer laser platforms have progressively improved outcomes and reduced complications." ”
- Source data from
- 2021-03-15
- Accessed
- 2026-04-18 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- Provides the population denominator: ~10-15 million US patients over 25 years, and notes that complication rates have declined with each technology generation. It does not state a specific serious-complication rate. This is a contextual source for procedure volume and the improving-safety trend, not a direct complication rate source.